These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene expression profiling of peripheral blood leukocytes identifies potential novel biomarkers of chronic obstructive pulmonary disease in current and former smokers. Edmiston JS; Archer KJ; Scian MJ; Joyce AR; Zedler BK; Murrelle EL Biomarkers; 2010 Dec; 15(8):715-30. PubMed ID: 20887155 [TBL] [Abstract][Full Text] [Related]
3. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics. Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361 [TBL] [Abstract][Full Text] [Related]
4. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152 [TBL] [Abstract][Full Text] [Related]
5. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Kittleson MM; Hare JM Trends Cardiovasc Med; 2005 May; 15(4):130-8. PubMed ID: 16099376 [TBL] [Abstract][Full Text] [Related]
6. Molecular profiling approaches for identifying novel biomarkers. Bailey WJ; Ulrich R Expert Opin Drug Saf; 2004 Mar; 3(2):137-51. PubMed ID: 15006720 [TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches in lung cancer biomarker development. Cho JY; Sung HJ Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125 [TBL] [Abstract][Full Text] [Related]
9. From microarrays to mechanisms of brain development and function. Díaz E Biochem Biophys Res Commun; 2009 Jul; 385(2):129-31. PubMed ID: 19460360 [TBL] [Abstract][Full Text] [Related]
10. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Kulasingam V; Diamandis EP Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711 [TBL] [Abstract][Full Text] [Related]
12. Data analysis of alternative splicing microarrays. Cuperlovic-Culf M; Belacel N; Culf AS; Ouellette RJ Drug Discov Today; 2006 Nov; 11(21-22):983-90. PubMed ID: 17055407 [TBL] [Abstract][Full Text] [Related]
13. Gene discovery in craniofacial development and disease--cashing in your chips. Handrigan GR; Buchtová M; Richman JM Clin Genet; 2007 Feb; 71(2):109-19. PubMed ID: 17250659 [TBL] [Abstract][Full Text] [Related]
14. [Approaches for identifying depression-related genes using animal models]. Nakatani N; Yoshikawa T Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):161-9. PubMed ID: 13677911 [TBL] [Abstract][Full Text] [Related]
15. Microarrays to identify new therapeutic strategies for cancer. Sears C; Armstrong SA Adv Cancer Res; 2007; 96():51-74. PubMed ID: 17161676 [TBL] [Abstract][Full Text] [Related]
16. Gene-environment interactions in the development of chronic obstructive pulmonary disease. Caramori G; Adcock I Curr Opin Allergy Clin Immunol; 2006 Oct; 6(5):323-8. PubMed ID: 16954784 [TBL] [Abstract][Full Text] [Related]
17. The application of microarray technology to neuropathology: cutting edge tool with clinical diagnostics potential or too much information? McShea A; Marlatt MW; Lee HG; Tarkowsky SM; Smit M; Smith MA J Neuropathol Exp Neurol; 2006 Nov; 65(11):1031-9. PubMed ID: 17086099 [TBL] [Abstract][Full Text] [Related]
19. [DNA microarrays--perspective of application for drug effectivity and safety evaluation]. Roman I Postepy Biochem; 2008; 54(1):107-15. PubMed ID: 18610588 [TBL] [Abstract][Full Text] [Related]
20. Novel and future applications of microarrays in toxicological research. Gant TW Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):599-608. PubMed ID: 17696809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]